$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Total Current Liabilities
$389.00M
Quarterly · Period ending: · USD

RARE Total Current Liabilities
Latest reported$384.00Mperiod ending
Latest reported$384.00Mperiod ending
RARE FY Current Liabilities ($999.00K → $384.00M)
Annual total current liabilities
High-resolution chart · PNG
What is total current liabilities?
Liabilities due within one year.
RARE total current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Current Liabilities (USD) |
|---|---|
| 384,000,000 | |
| 344,153,000 | |
| 280,437,000 | |
| 261,210,000 | |
| 181,368,000 | |
| 189,609,000 | |
| 103,300,000 | |
| 74,725,000 | |
| 71,014,000 | |
| 60,259,000 | |
| 27,918,000 | |
| 12,517,000 | |
| 5,921,000 | |
| 3,188,000 | |
| 999,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance